1.- Mandell GL, Petri WA. Antimicrobial Agents: drugs used in the chemotherapy of tuberculosis, Mycobacterium avium complex, and leprosy. In Goodman and Gilman's The Pliannacologycal Bais of Therapeutics McGraw Hill, New York, 9th edit capitulo 48:115-1174, 1996.
2.- Krucers A. Bennett NM. The use of antibiotics. A comprehesive review with clinical emphasis. London Heinemann. 4° edic. pag. 936:1987.
3.-Campbell I, Novelli V; Pozniak A. Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations 1998. AD:Royal Infinnary, Blackburn, London, United Kingdom. Thorax 53:536-548, 1998.
4.- Patel AM, McKeon ,J. Avoidance and managem ent of adverse reactions to antituberculosis drugs. Drug Safety 12:1-25, 1995.
5.- Robson SC, Pillans P, et al Treatment of tuberculosis in patients with pre-existing liver disease or following hepatotoxic drug reactions. SAW 83:432434,1993.
6.- Kahana LM,Ormerod LP. Hepatotoxicity antituberculosis drugs (2). Thorax 51:873-874, 1996.
7.- Anonimous. Tuberculosis Committee, Canadian Thoracic Society. Essential of tuberculosis control for the practising physician. Can Med Assoc J 150:15-61-71, 1994.
8.-Campbell IA, Omerod LP et al. Six months versus months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med 87:621-623, 1993.
9.- Campbell LA, Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment Tubercle 58:171-179, 1977.
10.- Campbell LA, Dyson AJ. Lymph node tuberculosis: a comparison of treatments 18 months after completion ofchemotherapy. Tuberde 60:95-98, 1979.
11 .- Artenstein AW, Kim JH, et al. Isolated poripheral tuberculous lymphadenitis in adults: curent clinical an diagnostic. Clin Infect Dis 20:876882, 1995.
12.- Singh J, Garg PK, Tandon RK. Hepatotoxicity due to entituberculosis therapy. Clinical profile and reintroduction of therapy. J Clin Gastroenterol 22:211-214, 1996
13.- Dahmash NS, Fayed DF, Chowdlurry MNH, Arora SC. Diagnostic challenge of tuberculosis of the eidedy in hospital: Exporience at a university hospital in Saudi Arabia. J Infect 31:93-97,1995.
14.- Dossing M, Wilcke JTR, Askgaard DS, Nybo B. Liver injury during antituberculosis treatment: An 11 -year study. Tubercle Loung Dis 77:335-340, 1996.